Leventhal L, Smith V, Hornby G, Andree TH, Brandt MR, and Rogers KE (2007)
Differential and synergistic effects of selective norepinephrine and serotonin re- uptake inhibitors in rodent models of pain. J Pharmacol Exp Ther 320:1178 –1185.
Lin MT, Wu JJ, Chandra A, and Tsay BL (1981) Activation of striatal dopamine
receptors induces pain inhibition in rats. J Neural Transm 51:213–222.
Magnusson JE and Fisher K (2000) The involvement of dopamine in nociception: The
role of D1 and D2 receptors in the dorsolateral striatum. Brain Res 855:260 –266.
Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355– 474.
Nahum-Levy R, Tam E, Shavit S, and Benveniste M (2002) Glutamate but not
glycine agonist affinity for NMDA receptors is influenced by small cations. J Neurosci 22:2550 –2560.
Owens MJ, Morgan WN, Plott SJ, and Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.
J Pharmacol Exp Ther 283:1305–1322.
Pedersen LH, Nielsen AN, and Blackburn-Munro G (2005) Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacol (Berlin) 182:551–561.
Popik P, Kostakis E, Krawczyk M, Nowak G, Szewczyk B, Krieter P, Chen Z, Russek
SJ, Gibbs TT, Farb DH, et al. (2006) The anxioselective agent DOV 51892 is more
efficacious than diazepam at enhancing GABA-gated currents at 1 subunit containing GABAA receptors. J Pharmacol Exp Ther 319:1244 –1252.
Rouzade M-L, Fioramonti J, and Bueno L (1998) Decrease in gastric sensitivity to
distension by 5-HT1A receptor agonists in rats. Dig Dis Sci 43:2048 –2054.
Sawynok J and Reid A (2001) Antinociception by tricyclic antidepressants in the rat
formalin test: differential effects on different behaviors following systemic and
spinal administration. Pain 93:51–59.
Semenchuk MR and Davis B (2000) Efficacy of sustained-release bupropion in
neuropathic pain: an open-label study. Clin J Pain 16:6 –11.
